 Athira Pharma ATHA stock is plummeting on Wednesday following the outcome of a Phase 2 clinical trial of fosgonimeton. The post Athira Pharma ATHA Stock Plunges 65 on Disappointing Drug Trial Results appeared first on InvestorPlace. 